OQS
ITOS

Occudo Quantitative Strategies’s iTeos Therapeutics ITOS Stock Holding History

Occudo Quantitative Strategies’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,073
Closed -$154K – 891
2023
Q4 		$154K Buy
+14,073
New +$140K 0.02% 677
2021
Q1 		– Sell
-7,139
Closed -$241K – 841
2020
Q4 		$241K Buy
+7,139
New +$189K 0.08% 487

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Occudo Quantitative Strategies's ITOS Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of iTeos Therapeutics (ITOS) in Q1 2024, closing a stake of 14,073 shares — an estimated $154K sold.

Occudo Quantitative Strategies first reported a position in ITOS in Q4 2020 and held it in 2 quarters. The position peaked at $241K in Q4 2020. 135 funds tracked by Wall St. Rank hold ITOS as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining iTeos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,073 iTeos Therapeutics shares in Q1 2024, an estimated $154K.
  • Occudo Quantitative Strategies first reported a position in iTeos Therapeutics in Q4 2020 and held it in 2 quarters.
  • Occudo Quantitative Strategies's iTeos Therapeutics position peaked at $241K in Q4 2020.
  • 135 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.